TaiMed Biologics Inc. (TPEX:4147)
Taiwan · Delayed Price · Currency is TWD 56.50
-1.50 (-2.59%)
Jul 29, 2026, 1:30 PM CST
TaiMed Biologics Market Cap
TaiMed Biologics has a market cap or net worth of 15.44 billion as of July 29, 2026. Its market cap has decreased by -31.74% in one year.
Market Cap
15.44B
Enterprise Value
14.29B
Revenue
601.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
56.50
ChartMarket Cap Chart
Since June 28, 2010, TaiMed Biologics's market cap has increased from 2.58B to 15.44B, an increase of 498.19%. That is a compound annual growth rate of 11.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 15.44B | -7.68% |
| Dec 31, 2025 | 16.72B | -28.81% |
| Dec 31, 2024 | 23.48B | 13.20% |
| Dec 29, 2023 | 20.75B | 16.27% |
| Dec 30, 2022 | 17.84B | 0.17% |
| Dec 30, 2021 | 17.81B | -16.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 22.22B |
| Sunmax Biotechnology | 20.86B |
| Medigen Vaccine Biologics | 15.50B |
| Lumosa Therapeutics | 15.09B |
| Ever Supreme Bio Technology | 15.01B |
| TCM Biotech International | 14.61B |
| EirGenix | 13.81B |
| ACRO Biomedical | 12.46B |